Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Balance Sheet
Balance Sheet Decomposition
Swedish Orphan Biovitrum AB (publ)
Current Assets | 12.1B |
Cash & Short-Term Investments | 527m |
Receivables | 8B |
Other Current Assets | 3.6B |
Non-Current Assets | 62.4B |
Long-Term Investments | 194m |
PP&E | 257m |
Intangibles | 61.1B |
Other Non-Current Assets | 827m |
Current Liabilities | 17.1B |
Accounts Payable | 671m |
Other Current Liabilities | 16.4B |
Non-Current Liabilities | 21.5B |
Long-Term Debt | 11.6B |
Other Non-Current Liabilities | 10B |
Balance Sheet
Swedish Orphan Biovitrum AB (publ)
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
519
|
904
|
786
|
1 478
|
2 999
|
737
|
404
|
1 045
|
1 361
|
904
|
|
Cash |
519
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Cash Equivalents |
0
|
904
|
786
|
1 478
|
2 999
|
737
|
404
|
1 045
|
1 361
|
904
|
|
Total Receivables |
594
|
584
|
1 256
|
1 523
|
2 165
|
4 625
|
4 523
|
4 105
|
6 141
|
7 062
|
|
Accounts Receivables |
532
|
517
|
769
|
1 459
|
2 072
|
4 095
|
4 058
|
3 760
|
5 583
|
6 460
|
|
Other Receivables |
62
|
68
|
487
|
64
|
93
|
530
|
465
|
345
|
558
|
602
|
|
Inventory |
764
|
776
|
870
|
1 053
|
1 284
|
1 772
|
3 053
|
3 424
|
3 332
|
3 874
|
|
Other Current Assets |
58
|
52
|
1
|
102
|
154
|
189
|
188
|
204
|
376
|
831
|
|
Total Current Assets |
1 935
|
2 316
|
2 911
|
4 157
|
6 602
|
7 323
|
8 168
|
8 778
|
11 210
|
12 671
|
|
PP&E Net |
115
|
113
|
121
|
134
|
136
|
518
|
534
|
493
|
274
|
251
|
|
PP&E Gross |
115
|
113
|
0
|
134
|
136
|
518
|
534
|
493
|
274
|
251
|
|
Accumulated Depreciation |
520
|
542
|
0
|
599
|
594
|
681
|
761
|
893
|
1 163
|
1 259
|
|
Intangible Assets |
2 693
|
4 233
|
5 252
|
4 891
|
8 605
|
30 734
|
32 918
|
32 136
|
33 006
|
50 478
|
|
Goodwill |
1 554
|
1 554
|
1 554
|
1 554
|
1 554
|
6 678
|
5 873
|
6 288
|
7 007
|
9 642
|
|
Long-Term Investments |
3
|
2
|
136
|
35
|
55
|
50
|
179
|
199
|
121
|
142
|
|
Other Long-Term Assets |
70
|
97
|
0
|
131
|
231
|
355
|
611
|
767
|
878
|
843
|
|
Other Assets |
1 554
|
1 554
|
1 554
|
1 554
|
1 554
|
6 678
|
5 873
|
6 288
|
7 007
|
9 642
|
|
Total Assets |
6 371
N/A
|
8 315
+31%
|
9 974
+20%
|
10 903
+9%
|
17 183
+58%
|
45 658
+166%
|
48 283
+6%
|
48 661
+1%
|
52 496
+8%
|
74 027
+41%
|
|
Liabilities | |||||||||||
Accounts Payable |
236
|
183
|
0
|
358
|
487
|
681
|
569
|
558
|
1 252
|
1 024
|
|
Accrued Liabilities |
451
|
550
|
0
|
1 119
|
1 610
|
3 039
|
3 928
|
4 967
|
5 253
|
5 248
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2 067
|
3 891
|
|
Current Portion of Long-Term Debt |
0
|
0
|
2
|
0
|
0
|
99
|
4 126
|
1 882
|
3 863
|
5 070
|
|
Other Current Liabilities |
60
|
587
|
1 756
|
888
|
4 854
|
1 922
|
1 820
|
1 354
|
2 422
|
3 862
|
|
Total Current Liabilities |
747
|
1 320
|
1 758
|
2 365
|
6 951
|
5 741
|
10 443
|
8 761
|
14 857
|
19 095
|
|
Long-Term Debt |
816
|
800
|
502
|
5
|
3
|
16 461
|
10 445
|
9 024
|
3 171
|
11 524
|
|
Deferred Income Tax |
272
|
313
|
0
|
668
|
664
|
3 726
|
3 464
|
3 605
|
3 797
|
6 680
|
|
Other Liabilities |
13
|
1 221
|
2 349
|
1 165
|
525
|
2 800
|
3 725
|
4 068
|
4 146
|
2 861
|
|
Total Liabilities |
1 848
N/A
|
3 655
+98%
|
4 609
+26%
|
4 202
-9%
|
8 143
+94%
|
28 728
+253%
|
28 077
-2%
|
25 458
-9%
|
25 971
+2%
|
40 160
+55%
|
|
Equity | |||||||||||
Common Stock |
149
|
149
|
0
|
150
|
150
|
165
|
167
|
169
|
170
|
194
|
|
Retained Earnings |
510
|
418
|
0
|
1 527
|
3 965
|
7 269
|
10 477
|
13 154
|
15 793
|
18 054
|
|
Additional Paid In Capital |
4 884
|
4 929
|
0
|
5 024
|
5 069
|
9 697
|
9 816
|
9 945
|
10 211
|
16 552
|
|
Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
56
|
82
|
|
Other Equity |
0
|
0
|
5 365
|
0
|
144
|
201
|
254
|
65
|
407
|
851
|
|
Total Equity |
4 523
N/A
|
4 660
+3%
|
5 365
+15%
|
6 701
+25%
|
9 040
+35%
|
16 930
+87%
|
20 206
+19%
|
23 203
+15%
|
26 525
+14%
|
33 867
+28%
|
|
Total Liabilities & Equity |
6 371
N/A
|
8 315
+31%
|
9 974
+20%
|
10 903
+9%
|
17 183
+58%
|
45 658
+166%
|
48 283
+6%
|
48 661
+1%
|
52 496
+8%
|
74 027
+41%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
267
|
268
|
269
|
269
|
270
|
294
|
309
|
309
|
310
|
340
|